Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of NUDT15 and ITPA Mutations and Clinical Outcomes in Pediatric Cancer Patients Receiving Mercaptopurine
TCTR20190828003Completed
- Sponsor
- Phramongkutklao Hospital and College of Medicine
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mercaptopurine in childhood cancer, sponsored by Phramongkutklao Hospital and College of Medicine. Primary endpoints: Prevalence of NUDT15 mutations, Prevalence of ITPA mutations and 1 more. Started Jan 2018; status: completed.
02
Drugs
mercaptopurine
03
Conditions
childhood cancer
Beyond the preview
Go deeper on TCTR20190828003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190828003.